Fragment 176-191 & Mod GRF 1-29 & Ipamorelin Blend (12mg)
$87.00
Fragment 176-191 & Mod GRF 1-29 & Ipamorelin Blend (12mg) is offered by Biotech Peptides for laboratory and analytical research. This blend combines a 16-residue growth hormone fragment, a 29-residue GHRH analogue, and a 5-residue ghrelin mimetic for studies of receptor signaling and neuroendocrine pathways.pubchem.ncbi.nlm.nih+1
-
Product: Fragment 176-191 & Mod GRF 1-29 & Ipamorelin Blend
-
Listed quantity: 12 mg
-
Components: Fragment 176-191, Mod GRF 1-29, and Ipamorelin
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
Fragment 176-191 & Mod GRF 1-29 & Ipamorelin Blend (12mg) for Laboratory Research
Fragment 176-191 & Mod GRF 1-29 & Ipamorelin Blend (12mg) is offered by Biotech Peptides for laboratories investigating growth hormone regulatory signaling, receptor convergence, and neuroendocrine feedback pathways. The blend combines Fragment 176-191, a synthetic 16-residue C-terminal fragment of human growth hormone, with Mod GRF 1-29, a synthetic 29-residue GHRH analogue, and Ipamorelin, a synthetic 5-residue ghrelin mimetic.pubchem.ncbi.nlm.nih+1
For laboratories looking to buy Fragment 176-191 & Mod GRF 1-29 & Ipamorelin Blend, this listing identifies a 12 mg quantity. Confirm the supplied material’s component ratio, salt state, and analytical characteristics against the requirements of the intended work.
Explore our research peptides for sale to review other laboratory-use listings.
Blend Product Information
| Property | Listing information |
|---|---|
| Product name | Fragment 176-191 & Mod GRF 1-29 & Ipamorelin Blend |
| Listed quantity | 12 mg |
| Components | Fragment 176-191, Mod GRF 1-29, and Ipamorelin |
| Intended application | Laboratory and analytical research |
| Documentation inquiries | Include the product name and batch or lot number, where available |
The 12 mg designation describes the total quantity stated for this listing. It does not independently establish the amount of each component, net peptide content, or confirm that a particular quantity-assay method has been performed.
Reference Molecular Characteristics
The following characteristics describe the reference structures of the three components. They are not analytical confirmation of an individual commercial blend batch.
| Component | Reference molecular formula | Approximate molecular weight | PubChem identifier |
|---|---|---|---|
| Fragment 176-191 | C₇₈H₁₂₅N₂₃O₂₃S₂ | 1817.1 g/mol | Not listed |
| Mod GRF 1-29 | C₁₅₂H₂₅₂N₄₄O₄₂ | 3367.9 g/mol | 91976842 |
| Ipamorelin | C₃₈H₄₉N₉O₅ | 711.9 g/mol | 9831659 |
The molecular formulas and molecular weights are documented in the PubChem CJC-1295 Without DAC reference record and the PubChem Ipamorelin reference record. Confirm the supplied salt state and any counterions against manufacturer specifications before using reference values in analytical calculations.pubchem.ncbi.nlm.nih
Fragment 176-191 is a synthetic 16-amino-acid C-terminal fragment of human growth hormone, corresponding to residues 176 through 191 of the parent hormone. The sequence is documented in the Fragment 176-191 research summary.direct-sarms
Mod GRF 1-29 is also known as CJC-1295 without DAC. It is a 29-amino-acid synthetic GHRH analogue. The sequence is documented in the PubChem CJC-1295 Without DAC reference record and in the Mod GRF 1-29 research summary.deusmedical
Ipamorelin is a synthetic 5-residue ghrelin mimetic with growth hormone-releasing activity. The sequence is documented in the PubChem Ipamorelin reference record.pubchem.ncbi.nlm.nih
Growth Hormone Pulsatility Research
A study evaluating a Modified GRF 1-29 analog reported that the peptide may enhance growth hormone release by 70% to 107% over a 12-hour period from somatotroph cells in the anterior pituitary gland. The same study reported an approximately 28% increase in IGF-1 levels.
A separate study reported that Ipamorelin may increase growth hormone levels to about 80 mIU/L, equivalent to 26.6 ng/mL, compared with baseline levels of 1.31 mIU/L, or 0.4 ng/mL, in controls.These findings apply to specific experimental protocols and do not establish that a commercial blend increases growth hormone in humans.
Research Limitations
Published Fragment 176-191, Mod GRF 1-29, and Ipamorelin research examines receptor signaling, cell-based assays, and animal models. It does not establish that a commercial blend increases growth hormone, improves body composition, supports bone health, reduces body fat, or treats any condition.pubchem.ncbi.nlm.nih+1
Published research also does not verify the identity, purity, component ratio, quantity, or biological activity of the commercial blend supplied with this listing.
Documentation and Batch Verification
Before selecting Fragment 176-191 & Mod GRF 1-29 & Ipamorelin Blend (12mg), review the information associated with the exact material being supplied. Depending on your protocol, relevant documentation may include:
-
Product name and batch or lot identifier.
-
Manufacturer specifications and chemical form.
-
Component ratio and total blend quantity.
-
Salt state and counterion information, where applicable.
-
Identity-testing methods and reported results.
-
Purity-testing methods and supporting analytical data.
-
Quantity or peptide-content measurements, where required.
-
Product-specific storage and handling instructions.
Match identifiers across the label, specifications, and analytical reports. Obtain clarification if the documentation uses inconsistent component ratios, sequences, or molecular values.
For inquiries, provide “Fragment 176-191 & Mod GRF 1-29 & Ipamorelin Blend (12mg),” the batch number where available, and the specific information your laboratory requires.
Storage and Handling
Follow the product-specific instructions supplied with the material and your laboratory’s applicable procedures.
Do not transfer storage temperatures, shelf-life claims, or preparation instructions from another supplier’s formulation or a differently modified peptide. Obtain clarification if documented instructions are unavailable or unclear.
Frequently Asked Questions About Fragment 176-191 & Mod GRF 1-29 & Ipamorelin Blend (12mg)
What is Fragment 176-191 & Mod GRF 1-29 & Ipamorelin Blend?
It is a research blend combining Fragment 176-191, a synthetic 16-residue C-terminal fragment of human growth hormone, with Mod GRF 1-29, a synthetic 29-residue GHRH analogue, and Ipamorelin, a synthetic 5-residue ghrelin mimetic.pubchem.ncbi.nlm.nih+1
What does the 12mg designation mean?
It is the total quantity stated for this listing. It does not describe the amount of each component, a concentration, or independently establish net peptide content.
Does this blend increase growth hormone?
Published research examines receptor signaling and growth hormone release in specific cell-based and animal models. It does not establish that a commercial blend increases growth hormone in humans.
Does published research verify this product?
No. Publications describe the materials and conditions used by the investigators. Assess a commercial blend using relevant manufacturer specifications and analytical evidence.
Where can I find delivery information?
Review our shipping information for current order-processing and delivery terms.
Research Use Only
Fragment 176-191 & Mod GRF 1-29 & Ipamorelin Blend (12mg) is sold for laboratory and analytical research only. Not for human or animal consumption, personal administration, medical treatment, diagnosis, or veterinary application.
Review our Research-Use-Only Policy before ordering.
| Brand | Biotech Peptides |
|---|
Related products
CJC-1295 (Mod GRF 1-29) & Ipamorelin & GHRP-2 Blend (9mg)
CJC-1295 (Mod GRF 1-29) & Ipamorelin & GHRP-2 Blend (9mg) is offered by Biotech Peptides for laboratory and analytical research. This blend combines a 29-residue GHRH analogue, a 5-residue ghrelin mimetic, and a 6-residue ghrelin mimetic for studies of receptor signaling and neuroendocrine pathways. 1096
-
Product: CJC-1295 (Mod GRF 1-29) & Ipamorelin & GHRP-2 Blend
-
Listed quantity: 9 mg
-
Components: CJC-1295, Ipamorelin, and GHRP-2
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
CJC-1295 & GHRP-2 Blend (10mg)
CJC-1295 & GHRP-2 Blend (10mg) is offered by Biotech Peptides for laboratory and analytical research. This reference blend combines CJC-1295 without DAC, a modified GHRH(1-29) analogue, with GHRP-2, a synthetic ghrelin-receptor agonist.
-
Product: CJC-1295 & GHRP-2 Blend
-
Components: CJC-1295 without DAC and GHRP-2
-
Listed quantity: 10 mg
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
CJC-1295 & Ipamorelin Blend (10mg)
CJC-1295 & Ipamorelin Blend (10mg) is offered by Biotech Peptides for laboratory and analytical research. This blend combines CJC-1295, a 29-residue GHRH analogue, with Ipamorelin, a 5-residue ghrelin mimetic, for studies of receptor signaling and neuroendocrine pathways. 1099
-
Product: CJC-1295 & Ipamorelin Blend
-
Listed quantity: 10 mg
-
Components: CJC-1295 and Ipamorelin
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
Mod GRF 1-29 & GHRP-2 Blend (10mg)
Mod GRF 1-29 & GHRP-2 Blend (10mg) is offered by Biotech Peptides for laboratory and analytical research. This blend combines Mod GRF 1-29, a 29-residue GHRH analogue, with GHRP-2, a 6-residue ghrelin mimetic, for studies of receptor signaling and neuroendocrine pathways. 1092
-
Product: Mod GRF 1-29 & GHRP-2 Blend
-
Listed quantity: 10 mg
-
Components: Mod GRF 1-29 and GHRP-2
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
Mod GRF 1-29 & GHRP-6 (10mg)
Mod GRF 1-29 & GHRP-6 (10mg) is offered by Biotech Peptides for laboratory and analytical research. This reference blend combines a modified GHRH(1-29) analogue with the synthetic hexapeptide GHRP-6, which has been studied in relation to growth-hormone secretion.pubmed.ncbi.nlm.nih+1
-
Product: Mod GRF 1-29 & GHRP-6
-
Components: Modified GRF(1-29) and GHRP-6
-
Listed quantity: 10 mg
-
Reference sequences: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂ and His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
Mod GRF 1-29 & Ipamorelin Blend (10mg)
Mod GRF 1-29 & Ipamorelin Blend (10mg) is offered by Biotech Peptides for laboratory and analytical research. This blend combines Mod GRF 1-29, a 29-residue GHRH analogue, with Ipamorelin, a 5-residue ghrelin mimetic, for studies of receptor signaling and neuroendocrine pathways. 1086
-
Product: Mod GRF 1-29 & Ipamorelin Blend
-
Listed quantity: 10 mg
-
Components: Mod GRF 1-29 and Ipamorelin
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
Sermorelin & GHRP-6 & GHRP-2 Blend (9mg)
Sermorelin & GHRP-6 & GHRP-2 Blend (9mg) is offered by Biotech Peptides for laboratory and analytical research. This blend combines a growth hormone-releasing hormone analogue with two growth hormone secretagogue receptor agonists for studies of receptor signaling and neuroendocrine pathways.pubchem.ncbi.nlm.nih
-
Product: Sermorelin & GHRP-6 & GHRP-2 Blend
-
Listed quantity: 9 mg
-
Components: Sermorelin, GHRP-6, and GHRP-2
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
Tesamorelin & Ipamorelin Blend (8mg)
Tesamorelin & Ipamorelin Blend (8mg) is offered by Biotech Peptides for laboratory and analytical research. This reference blend combines tesamorelin, a GHRH analogue, with ipamorelin, a synthetic ghrelin-receptor agonist.
-
Product: Tesamorelin & Ipamorelin Blend
-
Components: Tesamorelin and Ipamorelin
-
Listed quantity: 8 mg
-
Intended use: Laboratory and analytical research only
Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.
For research use only. Not for human consumption.
